| 1541 | Hepatic steatosis and fibrosis: Non-invasive assessment |
| 1542 | Understanding the role of PIN1 in hepatocellular carcinoma |
| 1543 | Reprogramming of glucose metabolism in hepatocellular carcinoma: Progress and prospects |
| 1544 | Percutaneous ablation of pancreatic cancer |
| 1545 | Epidemiology of pancreatic cancer |
| 1546 | Angiopoietin-2/angiopoietin-1 as non-invasive biomarker of cirrhosis in chronic hepatitis C |
| 1547 | Bibliometric analysis of top 100 cited articles in nonalcoholic fatty liver disease research |
| 1548 | Pulmonary complications of transcatheter arterial chemoembolization for hepatocellular carcinoma |
| 1549 | Mechanisms of the alternative activation of macrophages and non-coding RNAs in the development of radiation-induced lung fibrosis |
| 1550 | Immune checkpoint therapy for pancreatic cancer |
| © 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |